Corrine Savill, Chief Business Officer: Cullinan Therapeutics CGEM Sell · Filed 24/01/24

Trade details

Type: Insider sale
Amount: $265,597.36
Shares · price: 21,316 sh · $12.46 a share
Held after: 165,990 sh
Stock: Cullinan Therapeutics CGEM
Person: Corrine SavillChief Business Officer
Trade date: 24/01/23
Filed: 24/01/24
Days to filing: 1 days

Sold 11.4% of holdings

Share of holding sold: 11.4%

Cullinan Therapeutics trades, last 26 weeks

What else happened in Cullinan Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/24~24/02/22

Corrine Savill's recent trades

Corrine SavillChief Business Officer
Sell10b5-1 planCullinan Therapeutics
Sell10b5-1 plan
Cullinan Therapeutics
CGEM
$647.2K
40,000 sh
$647.2K
Filed 24/02/02
Traded 24/02/01
Corrine SavillChief Business Officer
Sell10b5-1 planCullinan Therapeutics
Sell10b5-1 plan
Cullinan Therapeutics
CGEM
$563.6K
40,000 sh
$563.6K
Filed 24/01/30
Traded 24/01/29
Corrine SavillChief Business Officer
Sell10b5-1 planCullinan Therapeutics
Sell10b5-1 plan
Cullinan Therapeutics
CGEM
$177.3K
14,559 sh
$177.3K
Filed 24/01/24
Traded 24/01/22
Corrine SavillChief Business Officer
Sell10b5-1 planCullinan Therapeutics
Sell10b5-1 plan
Cullinan Therapeutics
CGEM
$49.6K
4,125 sh
$49.6K
Filed 24/01/24
Traded 24/01/22